Cervical Cancer Screening Camp

Home » Cervical Cancer Screening Camp

MIOT Seychelles Medical, in collaboration with the Soroptimist International Club of Victoria, is conducting a FREE cervical cancer screening camp for women in Seychelles in observance of Cervical Cancer Awareness Month. The initiative focuses on early detection and improved access to preventive care for Seychellois women.

The Soroptimist International Club of Victoria, established in Seychelles in 1994, is a leading local NGO dedicated to advancing the health, education, and empowerment of women and girls through community outreach, advocacy, and fundraising initiatives.

This collaborative screening programme supports global efforts to prevent one of the most avoidable yet life-threatening cancers affecting women by promoting early detection and timely screening. Aligned with Cervical Cancer Prevention Week (19–25 January) and World Cancer Day (4 February), the initiative will offer free cervical cancer screening to the first 100 Seychellois women, reinforcing a shared commitment to prevention and women’s health.

Screening Camp Details

Screening Dates

19^th January to 4^th February 2026

Free Screening for the first 100 Seychellios women.

Appointments will be offered on a first-come, first-served basis.

Screening includes

Pap Smear + High-risk HPV co-testing and general physician consultation

Location

MIOT (Seychelles) Medical, T56 & S44, Espace Building, Ile Du Port, Mahé, Seychelles

Registration

To register, please call
+248 430 4499
or please fill out the form
below

Prior appointment is mandatory. Please carry previous medical records, if any.

Who Should Undergo this Screening?

Age

Do you need MIOT’s Cervical Cancer Screening?

Younger than 18

Not recommended.

18-65 years

Recommended once every 5 years.

Above 65 years

Recommended only if you have a history of cervical cancer.

Why Choose MIOT’s Cervical Cancer Screening?

Pap Smear (Conventional Screening)

MIOT’s Cervical Cancer Screening (Pap Smear + High-risk HPV Test)

Does not detect HPV infection but identifies cell abnormalities

Detects high-risk HPV infections before any cell abnormalities occur

Lower sensitivity (40-50% sensitivity)

High sensitivity (90% sensitivity)

Microscopic diagnosis

Molecular diagnosis (detects high-risk HPV strains) helps treatment decision

Routine screening test

Included in the latest guidelines of the American College of Obstetrics and Gynaecology (ACOG) and the World Health Organization (WHO)